• All sections
  • A - Human necessities
  • A61K - Preparations for medical, dental or toiletry purposes
  • A61K 47/68 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment

Patent holdings for IPC class A61K 47/68

Total number of patents in this class: 11753

10-year publication summary

378
567
989
1225
1204
1426
1485
1566
1548
751
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
SeaGen Inc
580
250
Regeneron Pharmaceuticals, Inc.
4223
198
Daiichi Sankyo Company, Limited
1849
197
Genentech, Inc.
3954
194
MedImmune Limited
610
149
Hanmi Pharm. Co., Ltd.
570
148
ImmunoGen, Inc.
399
130
Dyne Therapeutics, Inc.
237
126
The Regents of the University of California
19803
114
Novartis AG
10927
91
Bristol-myers Squibb Company
4897
90
Bolt Biotherapeutics, Inc.
119
90
Pfizer Inc.
3358
76
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
279
66
ADC Therapeutics SA
124
63
Hoffmann-La Roche Inc.
3369
60
Memorial Sloan-Kettering Cancer Center
1908
59
Abbvie Inc.
1800
58
CytomX Therapeutics, Inc.
216
58
Hangzhou DAC Biotech Co., Ltd
102
58
Other owners 9478